AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsitePizotifen malate, a derivative of benzocycloheptathiophene, is a tricyclic compound found to be a potent inhibitor of SR-2 receptor activity.
More Information Supplier PagePizotifen malate, a derivative of benzocycloheptathiophene, is a tricyclic compound found to be a potent inhibitor of SR-2 receptor activity.
More Information Supplier PagePizotifen malate, a derivative of benzocycloheptathiophene, is a tricyclic compound found to be a potent inhibitor of SR-2 receptor activity.
More Information Supplier PagePizotifen malate, a derivative of benzocycloheptathiophene, is a tricyclic compound found to be a potent inhibitor of SR-2 receptor activity.
More Information Supplier PagePizotifen malate, a derivative of benzocycloheptathiophene, is a tricyclic compound found to be a potent inhibitor of SR-2 receptor activity.
More Information Supplier PagePJ 34 hydrochloride is a potent inhibitor of poly(ADP-ribose) polymerase (PARP) (EC50 = 20 nM).
More Information Supplier PagePJ 34 hydrochloride is a potent inhibitor of poly(ADP-ribose) polymerase (PARP) (EC50 = 20 nM).
More Information Supplier PagePJ 34 hydrochloride is a potent inhibitor of poly(ADP-ribose) polymerase (PARP) (EC50 = 20 nM).
More Information Supplier PagePJ 34 hydrochloride is a potent inhibitor of poly(ADP-ribose) polymerase (PARP) (EC50 = 20 nM).
More Information Supplier PagePJ 34 hydrochloride is a potent inhibitor of poly(ADP-ribose) polymerase (PARP) (EC50 = 20 nM).
More Information Supplier PagePJ34 is a novel potent specific inhibitor of PARP-l/2 with EC50 of 20 nM.
More Information Supplier PagePJ34 is a novel potent specific inhibitor of PARP-l/2 with EC50 of 20 nM.
More Information Supplier PagePJ34 is a novel potent specific inhibitor of PARP-l/2 with EC50 of 20 nM.
More Information Supplier PagePK 44 phosphate is a potent inhibitor of dipeptidyl peptidase IV (DPP-IV) with an IC50 value of 15.8 nM.
More Information Supplier PagePKA inhibitor fragment (6-22) amide is a synthetic peptide that acts as a protein kinase inhibitor.
More Information Supplier PagePKA inhibitor fragment (6-22) amide is a synthetic peptide that acts as a protein kinase inhibitor.
More Information Supplier PagePKA inhibitor fragment (6-22) amide is a synthetic peptide that acts as a protein kinase inhibitor.
More Information Supplier PagePKC (19-36), pseudosubstrate peptide inhibitor of protein kinase C (IC50 = 0.18 uM).
More Information Supplier PagePKC (19-36), pseudosubstrate peptide inhibitor of protein kinase C (IC50 = 0.18 uM).
More Information Supplier PagePKC (19-36), pseudosubstrate peptide inhibitor of protein kinase C (IC50 = 0.18 uM).
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-??,??,??, ?? isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.
More Information Supplier PagePKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-??,??,??, ?? isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.
More Information Supplier PagePKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-??,??,??, ?? isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.
More Information Supplier PagePKI-587 is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-??,??,??, ?? isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.
More Information Supplier PagePKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.
More Information Supplier PagePKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.
More Information Supplier PagePKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.
More Information Supplier PagePladienolide B is the major analogue of a family of macrocyclic lactones isolated from Streptomyces platensis. Pladienolide B is a highly potent inhibitor of both hypoxia signals and cancer cell proliferation. Pladienolide B binds to SF3b complex blocking the spliceosome.
More Information Supplier PagePladienolide B is the major analogue of a family of macrocyclic lactones isolated from Streptomyces platensis. Pladienolide B is a highly potent inhibitor of both hypoxia signals and cancer cell proliferation. Pladienolide B binds to SF3b complex blocking the spliceosome.
More Information Supplier PagePladienolide B is the major analogue of a family of macrocyclic lactones isolated from Streptomyces platensis. Pladienolide B is a highly potent inhibitor of both hypoxia signals and cancer cell proliferation. Pladienolide B binds to SF3b complex blocking the spliceosome.
More Information Supplier PagePladienolide B is the major analogue of a family of macrocyclic lactones isolated from Streptomyces platensis. Pladienolide B is a highly potent inhibitor of both hypoxia signals and cancer cell proliferation. Pladienolide B binds to SF3b complex blocking the spliceosome.
More Information Supplier PagePlantamajoside was isolated and confirmed to have glycation inhibitory activity.
More Information Supplier PagePlantamajoside was isolated and confirmed to have glycation inhibitory activity.
More Information Supplier PagePlantamajoside was isolated and confirmed to have glycation inhibitory activity.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation.
More Information Supplier PagePlumbagin, exhibits cytotoxicity in rodent models of carcinogenesis and carcinoma; has antifungal, antiviral, and antibacterial action.
More Information Supplier Page
